Omidria Side Effects
Generic name: ketorolac / phenylephrine ophthalmic
Medically reviewed by Drugs.com. Last updated on May 5, 2023.
Note: This document contains side effect information about ketorolac / phenylephrine ophthalmic. Some dosage forms listed on this page may not apply to the brand name Omidria.
Applies to ketorolac/phenylephrine ophthalmic: ophthalmic solution.
Serious side effects of Omidria
Along with its needed effects, ketorolac/phenylephrine ophthalmic may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur while taking ketorolac / phenylephrine ophthalmic:
More common
- Decreased vision or other changes in vision
- loss of vision
Get emergency help immediately if any of the following symptoms of overdose occur while taking ketorolac / phenylephrine ophthalmic:
Symptoms of overdose
- Fainting
- fast, pounding, or irregular heartbeat or pulse
- fear or nervousness
- headache
- nausea
- vomiting
Other side effects of Omidria
Some side effects of ketorolac / phenylephrine ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- Feeling of having something in the eye
- red, sore eyes
For Healthcare Professionals
Applies to ketorolac / phenylephrine ophthalmic: intraocular solution.
Ocular
Very common (10% or more): Anterior chamber inflammation (24%)
Common (1% to 10%): Increased intraocular pressure, posterior capsule opacification, eye irritation, foreign body sensation in the eyes[Ref]
More about Omidria (ketorolac / phenylephrine ophthalmic)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: ophthalmic surgical agents
Patient resources
Professional resources
Related treatment guides
References
1. Product Information. Omidria (ketorolac-phenylephrine ophthalmic). Omeros Corporation. 2014.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Some side effects may not be reported. You may report them to the FDA.
